Farallon Capital Management LLC Elevation Oncology, Inc. Transaction History
Farallon Capital Management LLC
- $18.8 Billion
- Q4 2024
A detailed history of Farallon Capital Management LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,527,482 shares of ELEV stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,527,482Holding current value
$1.66 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding ELEV
# of Institutions
71Shares Held
39.1MCall Options Held
100Put Options Held
3.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$2.82 Million0.21% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$2.24 Million0.21% of portfolio
-
Bvf Inc San Francisco, CA2.97MShares$1.39 Million0.06% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.33 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$1.23 Million0.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $11M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...